#Ataxias

Live, measured metrics for the hashtag #Ataxias from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #ataxias

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$240.06/ year · 7-character #name
Claim #ataxias$240.06/yrBuy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
6
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 6
0
Avg reactions / post
Mastodon · last 6

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-07-30 23:23 UTC
0
07-24
0
07-25
0
07-26
0
07-27
0
07-28
0
07-29
0
07-30

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-07-30 23:23 UTC

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-07-30 23:23 UTC

Everything below is measured over the latest 6 public posts (spanning ~1176 hours).

Top of the latest posts

  • Therapeutic Strategies for Spinocerebellar Ataxia Type 1 (SCA1) #Neuroscience #Brain #NeurologicalDiseases #NeurodegenerativeDiseases #Neurodegeneration #Cerebellum #Ataxia #SpinocerebellarAtaxia #SCA1 #HereditaryAtaxias #Ataxias #Neurogene

    Javier Díaz-Nido@[email protected]002023-06-08 21:41 UTCView post →
  • Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases. Friedreich’s ataxia represents a test case to validate the potential of therapeutic strategies based on nanoparticles. #Neuroscience #Brain #Neurol

    Javier Díaz-Nido@[email protected]012023-06-05 12:13 UTCView post →
  • Vatiquinone found to slow Friedreich's Ataxia progression by 75% after 1.5 years But oral therapy fails to meet primary goal in Phase 2/3 trial #Neuroscience #Brain #NeurologicalDiseases #NeurodegenerativeDiseases #Neurodegeneration #Cerebe

    Javier Díaz-Nido@[email protected]002023-05-30 22:42 UTCView post →

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/ataxias